Related Experiment Video
Updated: Aug 17, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Systemic administration of propentofylline does not attenuate morphine tolerance in non-injured rodents
Jennifer A Shumilla1, Isa Samuels, Kirk W Johnson
1Neuropharmacology Group, Department of Preclinical Development, Avigen, Inc., 1301 Harbor Bay Parkway, Alameda, CA 94502, USA. jshumilla@avigen.com
Abstract:
Propentofylline is a phosphodiesterase inhibitor that has been shown to attenuate the onset of morphine tolerance when administered intrathecally to rats. The present studies examined whether systemic administration could be effective in attenuating morphine tolerance in non-injured rodents using a similar dosing paradigm. Propentofylline at 10, 30, or 50 mg/kg, administered intraperitoneally once daily for 5 days, was unable to attenuate morphine tolerance established by twice daily administration of 10 mg/kg morphine. These results suggest that direct delivery of propentofylline to the central nervous system (CNS) may be required in order to attenuate morphine tolerance.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Parenteral Anesthetics: Overview
Opioid Receptors: Overview
Desensitization and Tachyphylaxis
Several...

